However, Kan et al. found that there was no difference in serum Nesfatin-1 levels between tumor patients and normal individuals, but NUCB2 promotes colorectal cancer EMT through the LKB1/AMPK/mTORC1/ZEB1 pathway [27]. This evidence concerns the gene NUCB2 and colorectal cancer.